|
Volumn 10, Issue 4, 2012, Pages 353-354
|
In epigenetic therapy, less is more
|
Author keywords
[No Author keywords available]
|
Indexed keywords
5 AZA 2' DEOXYCYTIDINE;
AZACITIDINE;
CYCLIN DEPENDENT KINASE INHIBITOR 2A;
CYCLIN DEPENDENT KINASE INHIBITOR 2B;
DNA METHYLTRANSFERASE;
ACUTE GRANULOCYTIC LEUKEMIA;
APOPTOSIS;
BONE MARROW SUPPRESSION;
BREAST CANCER;
CANCER CELL CULTURE;
CANCER INHIBITION;
CARCINOGENICITY;
CELL CYCLE ARREST;
CELL STRUCTURE;
CELL SUBPOPULATION;
CLONOGENESIS;
CYTOTOXICITY;
DNA METHYLATION;
DNA SEQUENCE;
DOSE RESPONSE;
DRUG MEGADOSE;
ENZYME BINDING;
EPIGENETICS;
FIBROBLAST;
GENE MUTATION;
GENE REARRANGEMENT;
GENE SILENCING;
GENE THERAPY;
HUMAN;
MAXIMUM TOLERATED DOSE;
MYELODYSPLASTIC SYNDROME;
NONHUMAN;
NOTE;
PRIORITY JOURNAL;
|
EID: 84859554235
PISSN: 19345909
EISSN: 18759777
Source Type: Journal
DOI: 10.1016/j.stem.2012.03.012 Document Type: Short Survey |
Times cited : (25)
|
References (9)
|